SOPHiA GENETICS SA Files Routine 6-K Report
Ticker: SOPH · Form: 6-K · Filed: 2025-11-04T00:00:00.000Z
Sentiment: neutral
Topics: sec-filing, 6-K, compliance
TL;DR
SOPHIA GENETICS files a 6-K, nothing new, just procedural stuff for SEC compliance.
AI Summary
SOPHiA GENETICS SA filed a Form 6-K on November 4, 2025, for the period ending September 30, 2025. This report is a routine filing for foreign private issuers and is incorporated by reference into their existing Form F-3 registration statements (Registration Nos. 333-289266 and 333-289270). The filing does not contain specific financial results or operational updates beyond its procedural nature.
Why It Matters
This filing serves to update SEC filings and ensure ongoing compliance for SOPHiA GENETICS SA as a foreign private issuer. It incorporates previous documents into their active registration statements.
Risk Assessment
Risk Level: low — This is a routine procedural filing by a foreign private issuer and does not contain new material financial or operational information.
Key Players & Entities
- SOPHiA GENETICS SA (company) — Filer of the report
- 001-40627 (company) — SEC File Number
- 333-289266 (company) — Form F-3 Registration Number
- 333-289270 (company) — Form F-3 Registration Number
FAQ
What is the purpose of this Form 6-K filing for SOPHiA GENETICS SA?
The Form 6-K is a report of a foreign private issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of November 2025, and is incorporated by reference into the company's existing Form F-3 registration statements.
What period does this filing cover?
The Conformed Period of Report is 20250930, indicating it pertains to the period ending September 30, 2025.
What are the SEC file numbers associated with SOPHiA GENETICS SA's registration statements?
The filing mentions Registration No. 333-289266 and Registration No. 333-289270 for SOPHiA GENETICS SA's Form F-3 registration statements.
Where is SOPHiA GENETICS SA's principal executive office located?
SOPHiA GENETICS SA's principal executive office is located at La Pièce 12, CH-1180 Rolle, Switzerland.
Does this filing contain new financial results for SOPHiA GENETICS SA?
No, the filing is a routine report of a foreign private issuer and is incorporated by reference into existing registration statements; it does not appear to contain new specific financial results or operational updates beyond its procedural nature.
Filing Stats: 257 words · 1 min read · ~1 pages · Grade level 11 · Accepted 2025-11-04 06:24:00
Filing Documents
- q32025sophiageneticssa6-k.htm (6-K) — 15KB
- sophiageneticssaex991q32025.htm (EX-99.1) — 598KB
- sophiageneticssaex992q32025.htm (EX-99.2) — 387KB
- sophiageneticssaex993q32025.htm (EX-99.3) — 340KB
- 0001840706-25-000038.txt ( ) — 1341KB
Management's discussion and analysis of financial condition and results of operations
Management's discussion and analysis of financial condition and results of operations 99.3 Press release dated November 4 , 2025